v3.26.3
Note 5 - Earnings Per Common Share
3 Months Ended
Sep. 30, 2026
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 5 - EARNINGS PER COMMON SHARE

 

The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding:

 

(in thousands, except per share data)

 

Three Months Ended

 

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

 

 

​

 

 

 

​

BASIC EARNINGS PER SHARE

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

Net Income

 

$

7,127

 

 

$

7,264

 

 

 

 

 

​

 

 

 

​

Weighted average shares outstanding during the period, net of treasury shares

 

 

36,032

 

 

 

29,345

 

 

 

 

 

​

 

 

 

​

Weighted average vested restricted stock units outstanding

 

 

71

 

 

 

42

 

 

 

 

 

​

 

 

 

​

Weighted average shares outstanding in the Deferred Compensation Plan during the period

 

 

1,086

 

 

 

1,062

 

Weighted average shares outstanding

 

 

37,189

 

 

 

30,449

 

 

 

 

 

​

 

 

 

​

Basic income per share

 

$

0.19

 

 

$

0.24

 

 

 

 

 

​

 

 

 

​

DILUTED EARNINGS PER SHARE

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

Net Income

 

$

7,127

 

 

$

7,264

 

 

 

 

 

​

 

 

 

​

Weighted average shares outstanding

 

 

 

​

 

 

 

​

 

 

 

 

​

 

 

 

​

Basic

 

 

37,189

 

 

 

30,449

 

 

 

 

 

​

 

 

 

​

Effect of dilutive securities (a):

 

 

 

​

 

 

 

​

Impact of common shares to be issued under stock option plans, and contingently issuable shares, if any

 

 

699

 

 

 

932

 

Weighted average shares outstanding

 

 

37,888

 

 

 

31,381

 

 

 

 

 

​

 

 

 

​

Diluted income per share

 

$

0.19

 

 

$

0.23

 

 

 

 

 

​

 

 

 

​

Anti-dilutive securities (b)

 

 

121

 

 

 

-

 

 

 

(a)

Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.

 

 

(b)

Anti-dilutive securities were excluded from the computation of diluted net income per share for the three months ended September 30, 2026, because the exercise price was greater than the average fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares.